"10.1371_journal.pone.0028141","plos one","2011-12-07T00:00:00Z","Mihaela Campan; Melissa Moffitt; Sahar Houshdaran; Hui Shen; Martin Widschwendter; GÃ¼nter Daxenbichler; Tiffany Long; Christian Marth; Ite A Laird-Offringa; Michael F Press; Louis Dubeau; Kimberly D Siegmund; Anna H Wu; Susan Groshen; Uma Chandavarkar; Lynda D Roman; Andrew Berchuck; Celeste L Pearce; Peter W Laird","Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America; Department of Obstetrics and Gynecology Division of Gynecologic Oncology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America; Department of Biochemistry and Molecular Biology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America; Department of Gynecological Oncology, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, United Kingdom; Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria; Department of Obstetrics and Gynecology Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina, United States of America; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America; University of Southern California Epigenome Center, University of Southern California, Los Angeles, CA, United States of America; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America","Conceived and designed the experiments: PL MW. Performed the experiments: MM MC SH TL UC. Analyzed the data: HS MC MM PL. Contributed reagents/materials/analysis tools: MW GD CM MP LD KS AW SG LR AB IL-O. Wrote the paper: MC MM PL. Discussed the results, commented, and edited the manuscript: GD IL-O LD LDR AB CP AW.","PL is a consultant and Scientific Advisory Board member for Epigenomics AG. He holds issued patents on the MethyLight technology, which have been licensed to Epigenomics AG. This work was not supported by Epigenomics AG. Epigenomics had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript. In addition, PL and MC are named as inventors on a pending patent application for the Digital MethyLight technology. The patents and the relationship with Epigenomics do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors disclosed no potential competing interest.","2011","12","Mihaela Campan","MC",19,TRUE,2,5,4,3,TRUE,TRUE,TRUE,1,"9",FALSE
